Does Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy?
The company is hoping to expand, but is there enough here to attract growth investors?
Source: yahoo.com
Page 3 - Abiomed News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Abiomed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Abiomed Today - Breaking & Trending Today
The Pharmaceutical Industry Finds Itself At A Historical Crossroads - Bristol-Myers Squibb (NYSE:BMY)
Bristol Myers Squibb (NYSE: BMY), Merck & Co Inc (NYSE: MRK), Pfizer Inc (NYSE: PFE) and Johnson & Johnson(NYSE:
Source: benzinga.com
The Pharmaceutical Industry Finds Itself At A Historical Crossroads
Bristol Myers Squibb (NYSE: BMY), Merck & Co Inc (NYSE: MRK), Pfizer Inc (NYSE: PFE) and Johnson & Johnson(NYSE: JNJ) are facing the so-called patent cliffs which imply revenue of tens of billions of dollars between now and and the end of this decade is at risk. The expiration of patents for one or more leading branded products for a company means opening the door to competitors to sell copycats of those drugs, often at a competitive price. But, as always, pharmaceutical companies do their best
Source: yahoo.com
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
Income-seeking investors can look forward to steady payout raises from these pharma stocks.
Source: fool.com
Global Biobetters Market Analysis to 2034 by Drug Class,
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com